Master of Biomedical Innovation program integrates Sluice AI to propel health-care entrepreneurship
The Marnix E. Heersink School of Biomedical Innovation and Entrepreneurship at McMaster University announces the integration of Sluice AI into the Master of Biomedical Innovation (MBI) curriculum. This collaboration supports the program’s mission to bridge the gap between technology development and its successful commercialization in local, national, and international biomedical markets.
Sluice AI, a subscription-based online tool, is designed to accelerate the application of the Stanford Biodesign process by enabling AI-Human Co-creation of each step of the needs-driven innovation process. Through this partnership, MBI students will have access to Sluice AI, enhancing their ability to create impactful biomedical products to commercialize.
The platform will offer capabilities of in-depth need, technology, and market analysis, aiding students in navigating the complex landscape of biomedical innovation.
Dr. Alan Neville, Program Director of the Master of Biomedical Innovation program, said, “We are very pleased to be collaborating with Sluice AI to harness AI technology to enhance and accelerate our MBI students’ ability to generate commercially viable innovative solutions for biomedical problems in healthcare.”
Rush Bartlett, CEO of Sluice AI, stated, “Teaming up with the MBI program at McMaster University perfectly complements our goal to fuel groundbreaking healthcare innovations. At the forefront of Canadian healthcare education, McMaster nurtures visionary thinkers, and we are eager to empower these future leaders to drive transformative advancements in patient care.”
For more information about the Master of Biomedical Innovation program and the integration of Sluice AI, please visit our website or contact mbi@mcmaster.ca.
About the Marnix E. Heersink School of Biomedical Innovation and Entrepreneurship
The Marnix E. Heersink School of Biomedical Innovation and Entrepreneurship was founded in June 2022 and stems from a donation of more than $32 million Cdn made by Alabama physician and entrepreneur Marnix E. Heersink and his wife Mary to boost McMaster’s role as a hub for biomedical innovation, entrepreneurship and global health.
The Master of Biomedical Innovation (MBI) is the first graduate health-care entrepreneurship program of its kind in Canada and delivers a systematic, project-based approach to innovation and entrepreneurship, guiding students through problem identification, solution design, and business model development.
About Sluice AI
Sluice AI is a groundbreaking platform designed to revolutionize the process that surfaces hidden insights to create life-changing innovation. Leveraging a modular approach, Sluice AI facilitates the rapid identification of needs-driven insights and accelerates the birth of innovative ideas. This platform empowers founders, product developers, and investors to efficiently transition from idea to impact by integrating proven methodologies such as Biodesign, Lean, Design Thinking, and more. Sluice AI is used by leading organizations across the globe as an indispensable resource, providing a robust Needs-Driven framework for swift discovery and validation in an otherwise chaotic entrepreneurial landscape.